Position in TEVA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$3,012
-$109 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hurley Capital, LLC holds $299,687 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
7,435 | $280,596 | |
| 2 | GTBIF |
Green Thumb Industries Inc.
|
704 | $4,491 | |
| 3 | LFCR |
Lifecore Biomedical, Inc. \De\
|
1,148 | $4,270 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
100 | $3,012 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
460 | $2,976 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
526 | $2,945 | |
| 7 | CRLBF |
Cresco Labs Inc.
|
1,014 | $882 | |
| 8 | CRON |
Cronos Group Inc.
|
125 | $313 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,012 | 100 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,121 | 100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,020 | 100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,676 | 100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,537 | 100 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,204 | 100 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||